63 related articles for article (PubMed ID: 29064587)
1. An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome.
Hollander P; Rostgaard K; Smedby KE; Molin D; Loskog A; de Nully Brown P; Enblad G; Amini RM; Hjalgrim H; Glimelius I
Eur J Haematol; 2018 Jan; 100(1):88-97. PubMed ID: 29064587
[TBL] [Abstract][Full Text] [Related]
2. The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints.
Vardhana S; Younes A
Haematologica; 2016 Jul; 101(7):794-802. PubMed ID: 27365459
[TBL] [Abstract][Full Text] [Related]
3. Increasing microenvironment complexity in HL.
Chabay P
Blood; 2023 May; 141(19):2290-2291. PubMed ID: 37166929
[No Abstract] [Full Text] [Related]
4. Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma.
Wein F; Weniger MA; Höing B; Arnolds J; Hüttmann A; Hansmann ML; Hartmann S; Küppers R
Cancer Immunol Res; 2017 Dec; 5(12):1122-1132. PubMed ID: 29070649
[TBL] [Abstract][Full Text] [Related]
5. PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Xu-Monette ZY; Zhou J; Young KH
Blood; 2018 Jan; 131(1):68-83. PubMed ID: 29118007
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint Inhibition in Hodgkin Lymphoma - a Review.
Bröckelmann PJ; Engert A
Oncol Res Treat; 2017; 40(11):654-660. PubMed ID: 29065424
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the JAK/STAT pathway genes and activation of the pathway, a relevant finding in nodal Peripheral T-cell lymphoma.
Manso R; Sánchez-Beato M; González-Rincón J; Gómez S; Rojo F; Mollejo M; García-Cosio M; Menárguez J; Piris MA; Rodríguez-Pinilla SM
Br J Haematol; 2018 Nov; 183(3):497-501. PubMed ID: 29076126
[No Abstract] [Full Text] [Related]
8. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
9. Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Reinke S; Bröckelmann PJ; Iaccarino I; Garcia-Marquez M; Borchmann S; Jochims F; Kotrova M; Pal K; Brüggemann M; Hartmann E; Sasse S; Kobe C; Mathas S; Soekler M; Keller U; Bormann M; Zimmermann A; Richter J; Fuchs M; von Tresckow B; Borchmann P; Schlößer H; von Bergwelt-Baildon M; Rosenwald A; Engert A; Klapper W
Blood; 2020 Dec; 136(25):2851-2863. PubMed ID: 33113552
[TBL] [Abstract][Full Text] [Related]
10. Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma.
Calabretta E; d'Amore F; Carlo-Stella C
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694167
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome.
Werner L; Dreyer JH; Hartmann D; Barros MHM; Büttner-Herold M; Grittner U; Niedobitek G
Sci Rep; 2020 Jun; 10(1):9410. PubMed ID: 32523087
[TBL] [Abstract][Full Text] [Related]
12. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
Aoki T; Chong LC; Takata K; Milne K; Hav M; Colombo A; Chavez EA; Nissen M; Wang X; Miyata-Takata T; Lam V; Viganò E; Woolcock BW; Telenius A; Li MY; Healy S; Ghesquiere C; Kos D; Goodyear T; Veldman J; Zhang AW; Kim J; Saberi S; Ding J; Farinha P; Weng AP; Savage KJ; Scott DW; Krystal G; Nelson BH; Mottok A; Merchant A; Shah SP; Steidl C
Cancer Discov; 2020 Mar; 10(3):406-421. PubMed ID: 31857391
[TBL] [Abstract][Full Text] [Related]
13. Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment.
Ferrarini I; Rigo A; Zamò A; Vinante F
Leuk Lymphoma; 2019 Dec; 60(14):3395-3405. PubMed ID: 31304817
[TBL] [Abstract][Full Text] [Related]
14. Formation of the Immunosuppressive Microenvironment of Classic Hodgkin Lymphoma and Therapeutic Approaches to Counter It.
Aldinucci D; Borghese C; Casagrande N
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096713
[TBL] [Abstract][Full Text] [Related]
15. Preliminary Assessment of Tumor-Associated Tissue Eosinophilia (TATE) in Canine Mast Cell Tumors: Prevalence and Prognostic Relevance and Its Association with Neoangiogenesis.
Galietta V; Parisi F; Cocumelli C; Pierini A; Poli A; Scaramozzino P; Spallucci V; Millanta F
Animals (Basel); 2023 Jan; 13(2):. PubMed ID: 36670824
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of Epstein-Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis.
Hu J; Zhang X; Tao H; Jia Y
Front Oncol; 2022; 12():1034398. PubMed ID: 36387159
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint CD47 expression in classical Hodgkin lymphoma.
Gholiha AR; Hollander P; Löf L; Glimelius I; Hedstrom G; Molin D; Hjalgrim H; Smedby KE; Hashemi J; Amini RM; Enblad G
Br J Haematol; 2022 Jun; 197(5):580-589. PubMed ID: 35301709
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma.
Veldman J; Rodrigues Plaça J; Chong L; Terpstra MM; Mastik M; van Kempen LC; Kok K; Aoki T; Steidl C; van den Berg A; Visser L; Diepstra A
Oncoimmunology; 2022; 11(1):2033433. PubMed ID: 35111387
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients.
Karihtala K; Leivonen SK; Karjalainen-Lindsberg ML; Chan FC; Steidl C; Pellinen T; Leppä S
Blood Adv; 2022 Mar; 6(6):1919-1931. PubMed ID: 34941990
[TBL] [Abstract][Full Text] [Related]
20. High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis.
Li P; Yuan J; Ahmed FS; McHenry A; Fu K; Yu G; Cheng H; Xu ML; Rimm DL; Pan Z
Front Oncol; 2021; 11():701492. PubMed ID: 34527580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
